OBJECTIVE: Headache is one of the most common debilitating chronic pain conditions in either active or retired military personnel with mild traumatic brain injury (MTBI). This study assessed the effect of repetitive transcranial magnetic stimulation (rTMS) in alleviating MTBI-related headache (MTBI-HA). MATERIALS AND METHOD: Veterans with MTBI-HA were randomized to receive either real rTMS (REAL group) at 10 hz for a total of 2000 pulses divided into 20 trains with one-sec inter-train interval or sham rTMS (SHAM group) at the left motor cortex (LMC) with brain magnetic resonance imaging neuronavigation guidance. Pretreatment, posttreatment one-week and four-week headache and neuropsychological assessments were conducted. RESULT: Thirty veterans were screened and twenty four (21 men and 3 women with average year-old ± SD at 14.3 ± 12.6) subjects' data were analyzed. A two-factor (visit × treatment) repeated measures analysis of variance (RM-ANOVA) indicated a close to significant (p = 0.06) trend of interaction between pretreatment and posttreatment one-week assessment with the intensity of the persistent daily headache decreasing from 5.7 ± 1.9 to 2.2 ± 2.7 and 4.6 ± 1.3 to 3.5 ± 2.0 for the REAL and SHAM groups, respectively. Subsequent analyses indicated REAL group demonstrated a significantly (p = 0.041) higher % of reduction in persistent headache intensity than the SHAM group (56.3 ± 48.2% vs.15.4 ± 43.6%) at the posttreatment one-week assessment and the trend continued to the four-week assessment. Overall, a significantly (p = 0.035) higher percentage of the subjects in the REAL group (58.3%) demonstrated at least a 50% headache intensity reduction at posttreatment one-week assessment compared with the SHAM group (16.6%). The overall composite score of functionally debilitating headache exacerbation is significantly (p = 0.017) reduced in REAL group at the posttreatment four-week assessment in comparison with the SHAM group. No major sustained change in neuropsychological assessments was noted. CONCLUSION: The studied rTMS protocol appears to be a clinically feasible and effective treatment option in managing MTBI-HA.
OBJECTIVE: Headache is one of the most common debilitating chronic pain conditions in either active or retired military personnel with mild traumatic brain injury (MTBI). This study assessed the effect of repetitive transcranial magnetic stimulation (rTMS) in alleviating MTBI-related headache (MTBI-HA). MATERIALS AND METHOD: Veterans with MTBI-HA were randomized to receive either real rTMS (REAL group) at 10 hz for a total of 2000 pulses divided into 20 trains with one-sec inter-train interval or sham rTMS (SHAM group) at the left motor cortex (LMC) with brain magnetic resonance imaging neuronavigation guidance. Pretreatment, posttreatment one-week and four-week headache and neuropsychological assessments were conducted. RESULT: Thirty veterans were screened and twenty four (21 men and 3 women with average year-old ± SD at 14.3 ± 12.6) subjects' data were analyzed. A two-factor (visit × treatment) repeated measures analysis of variance (RM-ANOVA) indicated a close to significant (p = 0.06) trend of interaction between pretreatment and posttreatment one-week assessment with the intensity of the persistent daily headache decreasing from 5.7 ± 1.9 to 2.2 ± 2.7 and 4.6 ± 1.3 to 3.5 ± 2.0 for the REAL and SHAM groups, respectively. Subsequent analyses indicated REAL group demonstrated a significantly (p = 0.041) higher % of reduction in persistent headache intensity than the SHAM group (56.3 ± 48.2% vs.15.4 ± 43.6%) at the posttreatment one-week assessment and the trend continued to the four-week assessment. Overall, a significantly (p = 0.035) higher percentage of the subjects in the REAL group (58.3%) demonstrated at least a 50% headache intensity reduction at posttreatment one-week assessment compared with the SHAM group (16.6%). The overall composite score of functionally debilitating headache exacerbation is significantly (p = 0.017) reduced in REAL group at the posttreatment four-week assessment in comparison with the SHAM group. No major sustained change in neuropsychological assessments was noted. CONCLUSION: The studied rTMS protocol appears to be a clinically feasible and effective treatment option in managing MTBI-HA.
Authors: Kelly A Krese; Kyla Z Donnelly; Bella Etingen; Theresa L Bender Pape; Sarmistha Chaudhuri; Alexandra L Aaronson; Rachana P Shah; Dulal K Bhaumik; Andrea Billups; Sabrina Bedo; Mary Terese Wanicek-Squeo; Sonia Bobra; Amy A Herrold Journal: JMIR Res Protoc Date: 2022-06-15
Authors: Michael Vaninetti; Mike Lim; Aladdin Khalaf; Valerie Metzger-Smith; Matthew Flowers; Alphonsa Kunnel; Eric Yang; David Song; Lisa Lin; Alice Tsai; Roland Lee; Shahrokh Golshan; Albert Leung Journal: Sci Rep Date: 2021-05-05 Impact factor: 4.996
Authors: Albert Leung; Shivshil Shukla; Eric Yang; Bryan Canlas; Mawj Kadokana; Jason Heald; Ariea Davani; David Song; Lisa Lin; Greg Polston; Alice Tsai; Roland Lee Journal: Mol Pain Date: 2016-08-16 Impact factor: 3.395
Authors: Abrahão Fontes Baptista; Ana Mércia B L Fernandes; Katia Nunes Sá; Alexandre Hideki Okano; André Russowsky Brunoni; Argelia Lara-Solares; Aziza Jreige Iskandar; Carlos Guerrero; César Amescua-García; Durval Campos Kraychete; Egas Caparelli-Daquer; Elias Atencio; Fabián Piedimonte; Frantz Colimon; Fuad Ahmed Hazime; João Batista S Garcia; John Jairo Hernández-Castro; José Alberto Flores Cantisani; Kátia Karina do Monte-Silva; Luis Claudio Lemos Correia; Manuel Sempértegui Gallegos; Marco Antonio Marcolin; María Antonieta Ricco; María Berenguel Cook; Patricia Bonilla; Pedro Schestatsky; Ricardo Galhardoni; Valquíria Silva; William Delgado Barrera; Wolnei Caumo; Didier Bouhassira; Lucy S Chipchase; Jean-Pascal Lefaucheur; Manoel Jacobsen Teixeira; Daniel Ciampi de Andrade Journal: Pain Rep Date: 2019-01-09